FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Jul. 31, 2025

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The Company's assets and liabilities that were measured at fair value on a recurring basis are set forth by level within the fair value hierarchy in the following tables (in thousands):

	As of July 31, 2025
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance	$—	$354,823	$—	$354,823
Money market fund	7,370	—	—	7,370
Total assets	$7,370	$354,823	$—	$362,193
Liabilities:
Contingent consideration	$—	$—	$42,252	$42,252

	As of October 31, 2024
	Quoted Prices in Active Markets for Identical Assets (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)	Total
Assets:
Deferred compensation plan:
Corporate-owned life insurance	$—	$313,794	$—	$313,794
Money market fund	3,365	—	—	3,365
Total assets	$3,365	$313,794	$—	$317,159
Liabilities:
Contingent consideration	$—	$—	$30,207	$30,207

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

The following unobservable inputs were used to derive the estimated fair value of the Company's Level 3 contingent consideration liabilities as of July 31, 2025 ($ in thousands):

		Unobservable		Weighted
Acquisition Date	Fair Value	Input	Range	Average (1)
1-31-2025	$12,075	Compound annual revenue growth rate	5% - 22%	17%
		Discount rate	7.2% - 7.2%	7.2%
7-18-2022	21,534	Compound annual revenue growth rate	3% - 9%	7%
		Discount rate	7.7% - 7.7%	7.7%
3-17-2022	8,643	Compound annual revenue growth rate	(2%) - 6%	3%
		Discount rate	7.8% - 7.8%	7.8%

(1)    Unobservable inputs were weighted by the relative fair value of the contingent consideration liability.

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

Changes in the Company’s contingent consideration liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3) for the nine months ended July 31, 2025 are as follows (in thousands):

	Liabilities
Balance as of October 31, 2024	$30,207
Contingent consideration related to an acquisition	11,509
Increase in accrued contingent consideration, net	8,974
Payment of contingent consideration	(8,144)
Foreign currency transaction adjustments	(294)
Balance as of July 31, 2025	$42,252